Office of Inspector General (“OIG”) Advisory Opinion 25-09[1] addresses an inquiry from a company that develops, manufactures and sells medical devices used in emergency stroke treatment and provides commentary
Continue Reading Strict Compliance with Safe Harbor Requirements is Key to Avoiding Anti-Kickback Violations
On February 21, the FDA announced that the shortage of semaglutide injection products has been resolved. Semaglutide has appeared on the FDA’s Drug Shortage
Continue Reading End of Semaglutide Shortage Means Big Changes for Prescribers and Compounders
Introduction
In a significant move to enhance public health and expand HIV prevention measures, Florida has recently enacted the “John W. Rheay Act” (Fla. Stat. § 465.1861), effective
Continue Reading The John W. Rheay Act: A Step Forward in Florida’s Fight Against HIVTwo landmark cases fraught with False Claim Act (“FCA”) allegations of fraudulent billing for prescription drugs against food and pharmacy chains are making their way from the Seventh Circuit to
Continue Reading Is it Really Fraud? The Supreme Court Will Decide
On the heels of the Supreme Court decision in Xiulu Ruan v. United States, wherein the Supreme Court held that the government must prove beyond a reasonable doubt that
Continue Reading Creation of New Opioid Strike Force, Following Decision in Xiulu Ruan v. US, Signals Investigations of Physicians Will Intensify
A recent health care fraud conspiracy case resulted in federal prison sentences for six participants, serving as a warning to pharmacy owners and their employees. Read the full Department of
Continue Reading $8 Million Pharmacy Fraud Case Lands 6 Behind Bars
In the continued fight against opioid addiction, Pennsylvania enacted a new law, effective November 27, 2019, that requires prescribers in Pennsylvania to implement additional steps prior to treating a patient’s
Continue Reading PA Continues Fight Against Opioid Addiction with Opioid Treatment Agreements
In a severe act, Pennsylvania Gov. Wolf has ordered all health care providers, facilities, manufacturers, distributors and suppliers to report their inventory of personal protective equipment (PPE), certain pharmaceutical drugs
Continue Reading PA Gov. Orders All Health Care Providers to Report Inventory of PPE and Certain Drugs
Beginning on October 24, 2019, every licensed health care practitioner in Pennsylvania (excluding veterinarians) will be required to electronically prescribe controlled substances (regardless of the dosage) by sending the
Continue Reading Pennsylvania’s Electronic Prescription Requirement for Controlled Substances